Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02754960|
Recruitment Status : Withdrawn
First Posted : April 28, 2016
Last Update Posted : April 28, 2016
Shanghai Jiao Tong University School of Medicine
Information provided by (Responsible Party):
Zhizheng Ge, Shanghai Jiao Tong University School of Medicine
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Estimated Primary Completion Date :||March 2014|
|Estimated Study Completion Date :||September 2014|
Jacobson JM, Greenspan JS, Spritzler J, Ketter N, Fahey JL, Jackson JB, Fox L, Chernoff M, Wu AW, MacPhail LA, Vasquez GJ, Wohl DA. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med. 1997 May 22;336(21):1487-93.